Endothelial progenitor cell number and ERK phosphorylation serve as predictive and prognostic biomarkers in advanced hepatocellular carcinoma patients treated with sorafenib.
about
Circulating endothelial cells and their subsets: novel biomarkers for cancer.The role of tumor microenvironment in resistance to anti-angiogenic therapy.Monocytes/Macrophages promote vascular CXCR4 expression via the ERK pathway in hepatocellular carcinoma.Inhibition of insulin-like growth factor 1 receptor enhances the efficacy of sorafenib in inhibiting hepatocellular carcinoma cell growth and survival.
P2860
Endothelial progenitor cell number and ERK phosphorylation serve as predictive and prognostic biomarkers in advanced hepatocellular carcinoma patients treated with sorafenib.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Endothelial progenitor cell nu ...... tients treated with sorafenib.
@en
type
label
Endothelial progenitor cell nu ...... tients treated with sorafenib.
@en
prefLabel
Endothelial progenitor cell nu ...... tients treated with sorafenib.
@en
P2093
P2860
P1433
P1476
Endothelial progenitor cell nu ...... tients treated with sorafenib.
@en
P2093
Amit Anand Lugade
Austin Miller
Renuka Iyer
Suresh Gopi Kalathil
Yasmin Thanavala
P2860
P304
P356
10.1080/2162402X.2016.1226718
P577
2016-09-20T00:00:00Z